Johnson & Johnson will buy Swiss biotech firm Actelion for $30 billion (JNJ) | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/26/johnson-johnson-will-buy-swiss-biotech-firm-actelion-for-30-billion-jnj/

The offer represented a 23 percent premium to Actelion’s closing price on Wednesday of 227.4 Swiss francs. http://internationalnewslive.com/johnson-johnson-will-buy-swiss-biotech-firm-actelion-for-30-billion-jnj/